Disruptive, Impulse Control, and Conduct Disorders: all 56 studies

Page 1 of 1. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's DiseaseRecruitingNCT07505394Not applicable
• PET-MRI of Reward System in Parkinson's Disease With RBDRecruitingNCT07213219Not applicable
• Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's DiseaseRecruitingNCT07151378Phase 3
• Controlled Evaluation of an Exercise Program for Overweight AdolescentsEnrolling by invitationNCT06923865Not applicable
• LHC-CIDI-5 in Hong KongRecruitingNCT06804525
• Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.Not yet recruitingNCT06754553
• Inflammatory Challenge in Human Aggression.RecruitingNCT06665074Phase 2
• Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot StudyRecruitingNCT06639594Phase 1
• STIMPulseControl Ancillary Speech StudyRecruitingNCT06561919Not applicable
• Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControlRecruitingNCT06498349Not applicable
• Frontosubthalamic Networks in Parkinson's Disease.RecruitingNCT06485986Not applicable
• Maladaptive Anger TreatmentRecruitingNCT06275607Not applicable
• rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's DiseaseRecruitingNCT06237868Not applicable
• Neural Correlates During Alcohol IntoxicationRecruitingNCT06118580Phase 2
• Effect of Nitrous Oxide on Aggression.RecruitingNCT06118567Phase 2
• Pimavanserin and Aggression and Social Cognition.RecruitingNCT05895513Phase 2
• Neurostimulation Versus Therapy for Problems With EmotionsRecruitingNCT05712057Not applicable
• Restoring Cognitive Control (ReCon) in Acute Nicotine WithdrawalCompletedNCT03887429Phase 2Results posted
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive DisorderTerminatedNCT03420222Phase 2Results posted
• Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive DisorderCompletedNCT02055638Phase 1/2Results posted
• Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive DisorderCompletedNCT02048241Phase 4Results posted
• Inositol in TrichotillomaniaCompletedNCT01875445Phase 2Results posted
• N-Acetyl Cysteine in Pathologic Skin PickingCompletedNCT01063348Phase 2Results posted
• Naltrexone for Impulse Control Disorders in Parkinson's DiseaseCompletedNCT01052831Phase 4Results posted
• Memantine in the Treatment of KleptomaniaCompletedNCT00880685Phase 2Results posted
• Acamprosate in the Treatment of Pathological GamblingCompletedNCT00571103Phase 4Results posted
• Double-Blind Naltrexone in Compulsive Sexual BehaviorCompletedNCT00467558Phase 2Results posted
• Double-Blind Naltrexone in KleptomaniaCompletedNCT00332579Phase 2Results posted
• A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive DisorderCompletedNCT00078754Phase 2Results posted
• Drug Treatment for Pathologic Gambling DisorderCompletedNCT00053677Phase 3Results posted
• A Cognitive Bias Modification RCT for AggressionStatus unknownNCT04819230Not applicable
• Clinical Response of Impulsivity After Brain Stimulation in Parkinson's DiseaseStatus unknownNCT04811807
• Objective Assessment of Behavioural Disorders in PDActive, not recruitingNCT04611581
• Serotonin in Impulse Control Disorders in Parkinson's DiseaseStatus unknownNCT03970239Not applicable
• Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.CompletedNCT03947216Phase 2
• Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg SyndromeCompletedNCT03818243Not applicable
• Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease:CompletedNCT03552068Phase 2
• Better Understand Children and Adolescents' Intrafamilial Oppositional Defiant DisorderCompletedNCT03447535
• Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control DisordersTerminatedNCT03146130Phase 3
• Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label StudyStatus unknownNCT02934919Phase 2
• Effects of Non-invasive Brain Stimulation in Impulse Control DisordersStatus unknownNCT02927002Not applicable
• Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.Status unknownNCT02796040Not applicable
• fMRI in ImpulsivityCompletedNCT02755181
• Fingerprinting of ImpulsivityCompletedNCT02722174
• Behavioural Addiction and Genetics in Parkinson's DiseaseCompletedNCT02319395
• Remission of ICD by Switching Dopamine Agonist to Levodopa/CarbidopaCompletedNCT01683253Phase 4
• Mental Health Related to School Dropout in LuxembourgStatus unknownNCT01354236
• Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in AdolescentsCompletedNCT01111734Phase 1
• Testing a New Therapy for TrichotillomaniaCompletedNCT00872742Phase 2
• Psychotherapy for Intermittent Explosive DisorderCompletedNCT00667212Not applicable
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.CompletedNCT00399698Phase 3
• Psychiatric and Cognitive Manifestations of Parkinson's DiseaseCompletedNCT00360633
• Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment OrderTerminatedNCT00282165Phase 4
• A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IEDCompletedNCT00127400Phase 2
• Sertraline and Habit Reversal in the Treatment of Patients With TrichotillomaniaCompletedNCT00118014Phase 4
• Escitalopram for the Treatment of Self-Injurious Skin PickingCompletedNCT00115011Phase 4

← Disruptive, Impulse Control, and Conduct Disorders overview